Merck has won a trial level dismissal of claims brought by the State of Texas, alleging that its Vioxx promotional and sales efforts amounted to a fraud on the state pharmaceutical purchasing authorities. From the Yahoo! News version:
. . . .In its motion for summary judgment, Merck maintained, among other things, that the evidence showed that the company acted responsibly and truthfully in its communications about VIOXX with the State of Texas, doctors in the state and the U.S. Food and Drug Administration. . . .
Marginally-related aside, from the blog-author: Mr. Michael Specter, please see me after-school, this afternoon, for a tutorial -- and some Socratic Q & A.